Posted on October 18, 2016 by Sitemaster
A new paper in the journal Quality of Life Research has raised the question of whether it is possible to use available quality of life data from Phase III trials of new drugs in the treatment of advanced prostate cancer to make rational decisions about the use of those drugs in clinical practice. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: health-related, HRQOL, life, outcome, quality, survival | 4 Comments »
Posted on March 5, 2016 by Sitemaster
The ability and willingness of physicians to discuss issues related to sex, sexual function, and specific sexual activities with their patients (and their partners) before or after prostate cancer treatment is notoriously not seen to be high by most prostate cancer patients (although there are exceptions to that general rule). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: bisexual, gay, HRQOL, quality of life, sex | 2 Comments »
Posted on May 17, 2011 by Sitemaster
A poster presentation given on Sunday at the AUA annual meeting (and an associated media briefing) strongly suggested that gay males diagnosed with prostate cancer tend to have less good clinical outcomes than straight males. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: gay, health care related quality of life, HRQOL, sexual orientation | 2 Comments »
Posted on January 22, 2011 by Sitemaster
The Surgical Prostatectomy versus Interstitial Radiation Intervention Trial or SPIRIT was a Phase III, partially randomized clinical trial, conducted in the U.S.A. and Canada, and designed to compare radical prostatectomy (RP) and brachytherapy (BT) as first-line treatments for men with localized prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: brachytherapy, HRQOL, localized, outcome, quality of life, radical prostatectomy, SPIRIT | Leave a comment »
Posted on December 16, 2010 by Sitemaster
It has long been recognized that the combination of prostate cancer and diabetes tends to have a notable impact on the health-related quality of life (HRQoL) of male patients. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: diabetes, HRQOL, quality of life | Leave a comment »
Posted on April 5, 2010 by Sitemaster
Data to be published in the May 2010 issue of the Journal of Urology are going to make a lot of urologists rather less than happy about the implications for the use of radical prostatectomy as first-line treatment for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: brachytherapy, comparison, cryotherapy, HRQOL, outcome, quality of life, radical prostatectomy, RALP, RP | Leave a comment »
Posted on January 13, 2010 by Sitemaster
Today’s news reports summarize papers recently published on:
- Optimism, pessimism, and long-term health outcomes
- External beam radiation + hormone therapy for high-risk patients
- Quality of life and health utility after radical prostatectomy
- Paclitaxel + estradiol combination therapy in men progressing after docetaxel-based chemotherapy … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", estradiol, hormone therapy, HRQOL, optimism, outcomes, paclitaxel, pessimism, quality of life, radiation, radical prostatectomy | Leave a comment »
Posted on August 28, 2009 by Sitemaster
Having high socioeconomic status AND being in a strong, positive, and supportive relationship may have improved the health-related quality of life (HRQOL) of men with localized prostate cancer, according to a recent study. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: HRQOL, partners, quality of life | 1 Comment »
Posted on June 10, 2009 by Sitemaster
The decisions patients and their doctors make about which treatment to select as first-line therapy for localized prostate cancer are commonly based on perceptions and expectations about the side effects of these treatments, as well as on the curative potential of the therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: comparison, first line, HRQOL, outcomes, quality of life, Treatment | Leave a comment »
Posted on April 17, 2009 by Sitemaster
In today’s news reports we address:
- Prediction of freedom from biochemical failure after brachytherapy
- Prediction of probability of unilateral prostate cancer in men eligible for focal therapy
- Health-related quality of life 5 years after radiotherapy + androgen deprivation
- Androgen receptor activity “signatures” in men with CRPC … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: androgen receptor activity, brachytherapy, CRPC, dose, focal therapy, HRQOL, outcome, quality of life, signature, unilateral | Leave a comment »
Posted on March 4, 2009 by Sitemaster
It is well known to readers of The “New” Prostate Cancer InfoLink that androgen deprivation therapy (ADT) is a commonly used form of treatment for patients who experience biochemical recurrence (BCR) after first- or second-line therapy. However, as is also well known, the optimal timing of ADT initiation is uncertain, and earlier initiation of ADT can cause toxicities that lower patients’ health-related quality of life (HRQOL). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen deprivation therapy, anxiety, hormone therapy, HRQOL, quality of life | 3 Comments »
Posted on February 20, 2009 by Sitemaster
There are several news items again today. They deal with:
- Health-related quality of life of disadvantaged prostate cancer patients
- Post-surgical continence and preservation of the lateral fascia
- Relative health-related quality of life after radical prostatectomy and brachytherapy
- The activities of the protease-activated receptors PAR1 and PAR2
- Lymph node assessment and lymphadenectomy in management of prostate cancer
- Associations between total and ionized serum calcium and prostate cancer mortality … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: brachytherapy, continence, HRQOL, lymph node assessment, lymphadenectomy, mortality, protease-activated receptors, quality of life, radical prostatecftomy, serum calcium | Leave a comment »
Posted on January 2, 2009 by Sitemaster
Today’s news report contains items on:
- The estimation of localized prostate cancer tumor size based on PSA data alone
- Mitochondrial genes and prostate cancer risk
- Results of a Phase II trial of strontium-89 with chemohormonal therapy in men with metastatic bone disease
- The association between spirituality and quality of life in low-income patients with metastatic disease
We have provided separate reports on the results of a clinical trial of flaxseed in men diagnosed with prostate cancer pre-treatment and on the 5-year outcomes of younger men treated with brachytherapy as first-line therapy for localized prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: chemohormonal therapy, HRQOL, mitochondrial genes, quality of life, spirituality, strontium-89, tumor size | Leave a comment »